Loading...
Market
Global adoption of glowing dye for cancer surgeries by end of 2025?
3
Resolution / Starting Odds
Less than 5 countries • 25%
5 to 10 countries • 25%
10 to 20 countries • 25%
More than 20 countries • 25%
Global health and industry reports
Story
Scientists Develop Glowing Dye to Aid Prostate Cancer Surgery
Jun 10, 2024, 12:39 AM
Scientists have developed a groundbreaking glowing dye that adheres to cancer cells, providing surgeons with a powerful tool to identify and remove prostate cancer more effectively. This innovative dye makes previously invisible prostate tumors glow, allowing for more precise surgical removal of cancerous growths in real-time. The dye acts as a 'second pair of eyes' for doctors, enhancing their ability to detect and eradicate prostate cancer cells.
View original story
Similar markets
Fewer than 10 countries • 33%
10-20 countries • 33%
More than 20 countries • 34%
Less than 10 • 25%
10-20 • 25%
21-50 • 25%
More than 50 • 25%
< 10% adoption • 33%
10% to 30% adoption • 33%
> 30% adoption • 33%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
No expansion • 25%
1-3 countries • 25%
4-6 countries • 25%
More than 6 countries • 25%
Widely adopted • 25%
Moderately adopted • 25%
Rarely adopted • 25%
Not adopted • 25%
Widely adopted in over 50 countries • 25%
Adopted in 20-50 countries • 25%
Adopted in less than 20 countries • 25%
Not adopted widely • 25%
Under 100 hospitals • 33%
100-500 hospitals • 34%
Over 500 hospitals • 33%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
1-3 countries • 33%
4-6 countries • 33%
7+ countries • 33%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
North America only • 25%
Europe only • 25%
Asia only • 25%
Multiple continents • 25%